Pure Global AI
Registration holder profile

FRESENIUS HEMOCARE BRASIL LTDA.

Brazil123 ANVISA registrations33 unique technical categoriesJul 18, 1996 – Aug 10, 2026
123
Total products
33
Technical names
Jul 1996
Earliest registration
Aug 2026
Latest registration
Regulatory footprint
Search FRESENIUS HEMOCARE BRASIL LTDA. across other regulatory registries
Recent registrations
Latest 5 products registered by this holder
Most popular products
Products with most registrations
Top manufacturers
Manufacturers with the most products registered by this holder
Products per risk level
Distribution of distinct commercial products by ANVISA risk classification
Class I39Distinct Products · 43 total registrations
Class II6Distinct Products · 7 total registrations
Class III56Distinct Products · 57 total registrations
Class IV16Distinct Products · 16 total registrations
About this profile

Access comprehensive registration holder profile for FRESENIUS HEMOCARE BRASIL LTDA. through Pure Global AI's free Brazil medical device database. This registration holder manages 123 medical device registrations with ANVISA across 33 unique technical categories. Their regulatory portfolio spans from Jul 18, 1996 to Aug 10, 2026.

This page provides comprehensive insights including 5 recent product registrations with the latest being Apheresis System (COM.TEC Advance), 5 most popular products led by IMMUNOHEMATOLOGY - RED BLOOD CELL REAGENTS/ENZYME-TREATED RED BLOOD CELL REAGENTS with 21 registrations, partnerships with 5 key manufacturers including FRESENIUS KABI AG and IMMUCOR, INC, and products across 4 risk classifications with 39 Class I devices. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping distributors understand market dynamics and identify business opportunities.